Challenges to Achieving Measles Elimination, Georgia, 2013–2018
暂无分享,去创建一个
N. Khetsuriani | J. Hübschen | C. Muller | N. Chitadze | Shahin Huseynov | T. Dolakidze | M. Ben Mamou | R. Chlikadze | K. Zakhashvili | Ketevan Sanadze | T. Komakhidze | L. Jabidze
[1] N. Khetsuriani,et al. Measles and rubella seroprevalence among adults in Georgia in 2015: helping guide the elimination efforts , 2019, Epidemiology and Infection.
[2] P. Rota,et al. Progress Toward Regional Measles Elimination — Worldwide, 2000–2018 , 2019, MMWR. Morbidity and mortality weekly report.
[3] N. Khetsuriani,et al. High risk of subacute sclerosing panencephalitis following measles outbreaks in Georgia. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[4] M. Jit,et al. Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination , 2019, BMC medicine.
[5] S. Shulga,et al. Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[6] A. Pilav,et al. Epidemiologic and laboratory surveillance of the measles outbreak in the Federation of Bosnia and Herzegovina, February 2014-April 2015. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[7] Benhur Lee,et al. Constraints on the Genetic and Antigenic Variability of Measles Virus , 2016, Viruses.
[8] Sudhir Kumar,et al. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. , 2016, Molecular biology and evolution.
[9] J. Goodson. Progress Toward Regional Measles Elimination — Worldwide , 2016 .
[10] N. Khetsuriani,et al. Supplementary immunization activities to achieve measles elimination: experience of the European Region. , 2011, The Journal of infectious diseases.
[11] W. Bellini,et al. Global distribution of measles genotypes and measles molecular epidemiology. , 2011, The Journal of infectious diseases.
[12] N. Khetsuriani,et al. Impact of unfounded vaccine safety concerns on the nationwide measles-rubella immunization campaign, Georgia, 2008. , 2010, Vaccine.
[13] A. Uzicanin,et al. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts. , 2009, International journal of epidemiology.
[14] R. Pebody,et al. Nationwide measles epidemic in Ukraine: the effect of low vaccine effectiveness. , 2008, Vaccine.
[15] M. Mulders,et al. Measles outbreak in the Ukraine, 2005-2006. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[16] N. Khetsuriani,et al. Diphtheria epidemic in the Republic of Georgia, 1993-1997. , 2000, The Journal of infectious diseases.
[17] V. Tatochenko,et al. Contraindications to vaccination in the Russian Federation. , 2000, The Journal of infectious diseases.
[18] Birth Registration. , 1945, Journal of the National Medical Association.